Bacterial and fungal co-infection in individuals with COVID - 19

Authors

  • Yaumara Aguilera Calzadilla
  • Yayquier Díaz Morales
  • Elvys Pérez Bada
  • Jorge Manuel Pérez Milián
  • Berhlys Morales Rodríguez

Abstract

Introduction. The probability coexists that patients with severe COVID-19 may subsequently or coincidentally become infected by bacteria or fungi.
Methods-A descriptive study was carried out in the period from January to March 2021, at the Manuel Fajardo hospital, Villa Clara Province, Cuba. The study population consisted of 815 patients who remained admitted to that hospital with a confirmed diagnosis for the real-time polymerase chain reaction test for SARS-CoV-2. The study variables were: age, sex, months of the year, coinfection, state at discharge, isolated microorganisms and antimicrobial susceptibility. Results: 2, 7 % of the patients had an associated infection. 1, 9 % died and the majority of deaths occurred in the months of March and April. Among the deceased, 68, 8 % had an associated infection. Complot Acinetobacter baumannii calcoaceticus was the most isolated microorganism. Conclusions. Clinical data on bacterial and fungal infections are invaluable to guide evidence-based treatment of COVID-19. Therefore, a diagnostic protocol is required to determine bacterial and fungal associated infection in SARS-CoV-2.

Downloads

Published

2021-10-30

How to Cite

1.
Aguilera Calzadilla Y, Díaz Morales Y, Pérez Bada E, Pérez Milián JM, Morales Rodríguez B. Bacterial and fungal co-infection in individuals with COVID - 19. Invest Medicoquir [Internet]. 2021 Oct. 30 [cited 2025 Dec. 5];14(1). Available from: https://revcimeq.sld.cu/index.php/imq/article/view/755

Issue

Vol. 14 No. 1 (2022): Enero-Junio

Section

Research article

License

The authors retain copyright and all unrestricted publication rights.

Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.

You are free to:

  • Share — copy and redistribute the material in any medium or format.
  • Adapt — remix, transform, and build upon the material.

The license cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.